RBCs derived microparticles as hemostatic agents to control bleeding and to treat bleeding disorders

Microparticles derived from red blood cells (MPGR) or variants chemically modified of mismasproducidas by grafting or conjugation of adhesion molecules or recombinant clotting factors in lasuperficie of MPGR for use in a method of treatment of a condition of excessive bleeding in unmamifero increasing hemostasis.